{
    "root": "5f04cd24-b303-43dc-a963-f28d35a275ff",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "dicyclomine hydrochloride",
    "value": "20170601",
    "ingredients": [
        {
            "name": "DICYCLOMINE HYDROCHLORIDE",
            "code": "CQ903KQA31"
        },
        {
            "name": "D&C RED NO. 33",
            "code": "9DBA0SBB0L"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH"
        },
        {
            "name": "SORBITOL",
            "code": "506T60A25R"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "indications": "Dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome.",
    "contraindications": "Dosage must be adjusted to individual patient needs.",
    "warningsAndPrecautions": "Dicyclomine hydrochloride oral solution is supplied as a pinkish orange, tropical fruit punch-flavored syrup in bottles of 473 mL (16 fl oz.). Store at 20째 to 25째C (68째 to 77째F) [see USP Controlled Room Temperature]. Protect from excessive heat. Dispense in a tight container with a child-resistant closure.",
    "adverseReactions": "Dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see Use in Specific Populations (8.4)], nursing mothers [see Use in Specific Populations (8.3)], and in patients with:\n\n                  \n                     unstable cardiovascular status in acute hemorrhage\n    \n                     myasthenia gravis [see Warnings and Precautions (5.4)]\n                     \n                     glaucoma [see Adverse Reactions (6.3) and\n    Drug Interactions (7.1)]\n                     \n                     obstructive uropathy [see Warnings and Precautions (5.8)]\n                     \n                     obstructive disease of the gastrointestinal tract [see Warnings and Precautions (5.5)]\n                     \n                     severe ulcerative colitis [see Warnings and Precautions (5.7)]\n                     \n                     reflux esophagitis"
}